Angiopoietin-2-induced arterial stiffness in CKD

Journal of the American Society of Nephrology

Volumn 25, Issue 6, 2014, Pages 1198-1209

  Chang, Fan Chi ^a,b   Chiang, Wen Chih ^b   Tsai, Ming Hsuan ^a   Chou, Yu Hsiang ^a,b   Pan, Szu Yu ^b   Chang, Yu Ting ^a   Yeh, Pei Ying ^a   Chen, Yi Ting ^a,b   Chiang, Chih Kang ^b   Chen, Yung Ming ^b   Chu, Tzong Shinn ^b   Wu, Kwan Dun ^b   Lin, Shuei Liong ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; TRANSFORMING GROWTH FACTOR BETA1; ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; ANGPT1 PROTEIN, HUMAN; ANGPT1 PROTEIN, MOUSE; ANGPT2 PROTEIN, HUMAN; COLLAGEN; TRANSCRIPTOME; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERIAL STIFFNESS; ARTICLE; CHRONIC KIDNEY DISEASE; COLLAGEN GENE; CONTROLLED STUDY; ENDOTHELIUM CELL; EPITHELIUM CELL; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IN VIVO STUDY; KIDNEY TUBULE CELL; LUNG; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOUSE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; PROFIBROTIC GENE; PROTEIN EXPRESSION; PULSE WAVE; SMOOTH MUSCLE FIBER; URETER OBSTRUCTION; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; BLOOD; C57BL MOUSE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DISEASE MODEL; FIBROSIS; IMMUNOLOGY; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

AGED; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; AORTA; COLLAGEN; CROSS-SECTIONAL STUDIES; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; FIBROSIS; HUMANS; INFLAMMATION; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; RECEPTOR, TIE-2; RENAL INSUFFICIENCY, CHRONIC; TRANSCRIPTOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR STIFFNESS;

EID: 84906097639     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013050542     Document Type: Article

References (45)

1. Levin A, Foley RN: Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 36[Suppl 3]: S24-S30, 2000
2. Foley RN,MurrayAM, Li S,HerzogCA, McBeanAM, Eggers PW, Collins AJ: Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J AmSoc Nephrol 16: 489-495, 2005
3. Briet M, Collin C, Karras A, Laurent S, Bozec E, Jacquot C, Stengel B, Houillier P, FroissartM, Boutouyrie P; Nephrotest Study Group: Arterial remodeling associates with CKD progression. J Am Soc Nephrol 22: 967-974, 2011
4. Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23: 1725-1734, 2012
5. Guerin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 103: 987-992, 2001
6. Upadhyay A, Hwang S-J, Mitchell GF, Vasan RS, Vita JA, Stantchev PI, Meigs JB, Larson MG, Levy D, Benjamin EJ, Fox CS: Arterial stiffness in mild-to-moderate CKD. J Am Soc Nephrol 20: 2044-2053, 2009
7. Willum-Hansen T, Staessen JA, Torp-Pedersen C, Rasmussen S, Thijs L, Ibsen H, Jeppesen J: Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population. Circulation 113: 664-670, 2006
8. Mitchell GF, Hwang SJ, Vasan RS, Larson MG, Pencina MJ, Hamburg NM, Vita JA, Levy D, Benjamin EJ: Arterial stiffness and cardiovascular events: The Framingham Heart Study. Circulation 121: 505-511, 2010
9. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, Robinson NA, Joffe M: Aortic PWV in chronic kidney disease: A CRIC ancillary study. Am J Hypertens 23: 282-289, 2010
10. van Bussel BC, Henry RM, Schalkwijk CG, Dekker JM, Nijpels G, Stehouwer CD: Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: The Hoorn Study. J Hypertens 30: 744-752, 2012
11. Mäki-Petäjä KM, ElkhawadM, Cheriyan J, Joshi FR, Ostör AJK, Hall FC, Rudd JHF, Wilkinson IB: Anti-tumor necrosis factor-a therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis. Circulation 126: 2473-2480, 2012
12. London GM, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F: Cardiac and arterial interactions in end-stage renal disease. Kidney Int 50: 600-608, 1996
13. Muntner P, He J, Hamm L, Loria C,Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13: 745-753, 2002
14. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12: 2131-2138, 2001
15. LondonGM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18: 613-620, 2007
16. Tsai MC, Chen L, Zhou J, Tang Z, Hsu TF, Wang Y, Shih YT, Peng HH, Wang N, Guan Y, Chien S, Chiu JJ: Shear stress induces syntheticto-contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator-activated receptor a/delta activations by prostacyclin released by sheared endothelial cells. Circ Res 105: 471-480, 2009
17. Chen YM, Wu KD, Tsai TJ, Hsieh BS: Pentoxifylline inhibits PDGFinduced proliferation of and TGF-beta-stimulated collagen synthesis by vascular smooth muscle cells. J Mol Cell Cardiol 31: 773-783, 1999
18. Jamal SA, Fitchett D, Lok CE,Mendelssohn DC, Tsuyuki RT: The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: A meta-analysis. Nephrol Dial Transplant 24: 3168-3174, 2009
19. Lemström KB, Krebs R, Nykänen AI, Tikkanen JM, Sihvola RK, Aaltola EM, Häyry PJ,Wood J, Alitalo K, Ylä-Herttuala S, Koskinen PK: Vascular endothelial growth factor enhances cardiac allograft arteriosclerosis. Circulation 105: 2524-2530, 2002
20. David S, Kümpers P, Hellpap J, Horn R, Leitolf H, Haller H, Kielstein JT: Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation. Am J Kidney Dis 53: 770-778, 2009
21. Shroff RC, Price KL, Kolatsi-JoannouM, Todd AF,Wells D, Deanfield J, Johnson RJ, Rees L, Woolf AS, Long DA: Circulating angiopoietin-2 is a marker for early cardiovascular disease in children on chronic dialysis. PLoS ONE 8: e56273, 2013
22. David S, Kümpers P, Lukasz A, Fliser D, Martens-Lobenhoffer J, Bode-Böger SM, Kliem V, Haller H, Kielstein JT: Circulating angiopoietin-2 levels increase with progress of chronic kidney disease. Nephrol Dial Transplant 25: 2571-2576, 2010
23. David S, John SG, Jefferies HJ, Sigrist MK, Kümpers P, Kielstein JT, Haller H, McIntyre CW: Angiopoietin-2 levels predict mortality in CKD patients. Nephrol Dial Transplant 27: 1867-1872, 2012
24. Chang FC, Lai TS,Chiang CK, ChenYM,WuMS, Chu TS,WuKD, Lin SL: Angiopoietin-2 is associated with albuminuria and microinflammation in chronic kidney disease. PLoS ONE 8: e54668, 2013
25. Gale NW, Yancopoulos GD: Growth factors acting via endothelial cellspecific receptor tyrosine kinases: VEGFs, angiopoietins, and ephrins in vascular development. Genes Dev 13: 1055-1066, 1999
26. Felcht M, Luck R, Schering A, Seidel P, Srivastava K, Hu J, Bartol A, Kienast Y, Vettel C, Loos EK, Kutschera S, Bartels S, Appak S, Besemfelder E, Terhardt D, Chavakis E,Wieland T, Klein C, ThomasM, Uemura A, Goerdt S, Augustin HG: Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling. J Clin Invest 122: 1991-2005, 2012
27. Jeansson M, Gawlik A, Anderson G, Li C, Kerjaschki D, Henkelman M, Quaggin SE: Angiopoietin-1 is essential in mouse vasculature during development and in response to injury. J Clin Invest 121: 2278-2289, 2011
28. Woolf AS, Gnudi L, Long DA: Roles of angiopoietins in kidney development and disease. J AmSoc Nephrol 20: 239-244, 2009
29. Fiedler U, Reiss Y, Scharpfenecker M, Grunow V, Koidl S, Thurston G, Gale NW, Witzenrath M, Rosseau S, Suttorp N, Sobke A, Herrmann M, Preissner KT, Vajkoczy P, Augustin HG: Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med 12: 235-239, 2006
30. ThurstonG, Rudge JS, Ioffe E, ZhouH,Ross L, Croll SD, Glazer N,Holash J, McDonald DM, Yancopoulos GD: Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6: 460-463, 2000
31. Maisonpierre PC, Suri C, Jones PF, Bartunkova S,Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, SatoTN, YancopoulosGD:Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277: 55-60, 1997
32. Tressel SL, Kim H, Ni CW, Chang K, Velasquez-Castano JC, Taylor WR, Yoon YS, Jo H: Angiopoietin-2 stimulates blood flow recovery after femoral artery occlusion by inducing inflammation and arteriogenesis. Arterioscler Thromb Vasc Biol 28: 1989-1995, 2008
33. Pinsky DJ, Naka Y, Liao H, Oz MC, Wagner DD, Mayadas TN, Johnson RC, Hynes RO, Heath M, Lawson CA, Stern DM: Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation.J Clin Invest 97: 493-500, 1996
34. Makinde TO, Agrawal DK: Increased expression of angiopoietins and Tie2 in the lungs of chronic asthmatic mice. Am J Respir Cell Mol Biol 44: 384-393, 2011
35. LimHS, Lip GY, Blann AD: Angiopoietin-1 and angiopoietin-2 in diabetes mellitus: Relationship to VEGF, glycaemic control, endothelial damage/dysfunction and atherosclerosis. Atherosclerosis 180: 113-118, 2005
36. Post S, PeetersW, Busser E, Lamers D, Sluijter JP, GoumansMJ, de Weger RA, Moll FL, Doevendans PA, Pasterkamp G, Vink A: Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density. J Vasc Res 45: 244-250, 2008
37. Weber C, Meiler S, Döring Y, Koch M, Drechsler M, Megens RTA, Rowinska Z, Bidzhekov K, Fecher C, Ribechini E, van ZandvoortMAMJ, Binder CJ, Jelinek I, HristovM, Boon L, Jung S, Korn T, LutzMB, Förster I, Zenke M, Hieronymus T, Junt T, Zernecke A: CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T-cell homeostasis in mice. J Clin Invest 121: 2898-2910, 2011
38. Coffelt SB, Tal AO, Scholz A, De Palma M, Patel S, Urbich C, Biswas SK, Murdoch C, Plate KH, Reiss Y, Lewis CE: Angiopoietin-2 regulates gene expression in TIE2-expressing monocytes and augments their inherent proangiogenic functions. Cancer Res 70: 5270-5280, 2010
39. Lin SL, Castaño AP, Nowlin BT, LupherML Jr, Duffield JS: Bone marrow Ly6Chigh monocytes are selectively recruited to injured kidney and differentiate into functionally distinct populations. J Immunol 183: 6733-6743, 2009
40. Castaño AP, Lin SL, Surowy T,Nowlin BT, Turlapati SA, Patel T, Singh A, Li S, LupherML Jr,Duffield JS: Serumamyloid P inhibits fibrosis through Fc gamma R-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 1: 5-13, 2009
41. Lin SL, Li B, Rao S, Yeo EJ, Hudson TE, Nowlin BT, Pei H, Chen L, Zheng JJ, Carroll TJ, Pollard JW, McMahon AP, Lang RA, Duffield JS: MacrophageWnt7b is critical for kidney repair and regeneration. Proc Natl Acad Sci U S A 107: 4194-4199, 2010
42. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D; Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Ann Intern Med 130: 461-470, 1999
43. Kuo HK, Chen CY, Liu HM, Yen CJ, Chang KJ, Chang CC, Yu YH, Lin LY, Hwang JJ: Metabolic risks, white matter hyperintensities, and arterial stiffness in high-functioning healthy adults. Int J Cardiol 143: 184-191, 2010
44. Lin SL, Kisseleva T, Brenner DA, Duffield JS: Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol 173: 1617-1627, 2008
45. Leelahavanichkul A, YanQ, Hu X, Eisner C, Huang Y, Chen R,Mizel D, Zhou H, Wright EC, Kopp JB, Schnermann J, Yuen PS, Star RA: Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int 78: 1136-1153, 2010